Precigen prepares to launch main product following earnings

Precigen, Inc. held its fourth-quarter earnings call for 2024 on March 19, 2025. The conference was led by several company officials, including President and CEO Dr. Helen Sabzevari and CFO Harry Thomasian. The call began with a reminder about forward-looking statements. Investors were warned that predictions made during the meeting could vary due to risks and uncertainties. Dr. Sabzevari stated it is a crucial time for Precigen. The company is approaching the commercialization of its main products. The team expressed optimism about the future and discussed the company’s performance in the past year. The call included a question-and-answer session after the prepared remarks. Financial analysts from various institutions participated, looking to gain insights into the company's progress and strategy.